The Exchange has sought clarification from Glenmark Pharmaceuticals Limited, with respect to recent news item captioned “Setback For Glenmark: Sanofi Not To Pursue Development Of Vatelizumab Molecule”. In this regard, the……
| Subscribe To Our Free Newsletter |
